WPC
BSX icon

Waters Parkerson & Co’s Boston Scientific BSX Stock Holding History

Waters Parkerson & Co’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Sell
234,288
-60,889
-21% -$3.31M 0.49% 45
2026
Q1 		$18.5M Buy
295,177
+30,693
+12% +$2.46M 0.95% 32
2025
Q4 		$25.2M Buy
+264,484
New +$25.9M 1.24% 30

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Waters Parkerson & Co's BSX Position: Q2 2026 in Review

Waters Parkerson & Co reduced its Boston Scientific (BSX) stake by 21% in Q2 2026, selling an estimated $3.31M and leaving 234,288 shares worth $10M. The position accounts for 0.49% of the portfolio, ranked #45.

Waters Parkerson & Co first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $25.2M in Q4 2025. 1,485 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Waters Parkerson & Co held 234,288 shares of Boston Scientific worth $10M as of Q2 2026.
  • Waters Parkerson & Co sold 60,889 Boston Scientific shares in Q2 2026, an estimated $3.31M.
  • Boston Scientific made up 0.49% of Waters Parkerson & Co's portfolio in Q2 2026, its #45 holding.
  • Waters Parkerson & Co first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Waters Parkerson & Co's Boston Scientific position peaked at $25.2M in Q4 2025.
  • 1,485 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.